Antimicrobial agents and chemotherapy

• 

  Año 2006, Vol. 50, Número 4

  • Autolytic Properties of Glycopeptide-Intermediate Staphylococcus aureus Mu50

    R. F. Pfeltz, R. K. Jayaswal, B. J. Wilkinson, S. Utaida

    págs. 1541-1545

    

  • Quadruple Mutations in Dihydrofolate Reductase of Plasmodium falciparum from Car Nicobar Island, India

    Y. D. Wajihullah; Sharma, M. K. Das, A. Ahmed

    págs. 1546-1549

    

  • Genetic Basis of Tetracycline and Minocycline Resistance in Potentially Probiotic Lactobacillus plantarum Strain CCUG 43738

    Geert Huys, K. D'Haene

    págs. 1550-1551

    

  • In Vivo Efficacy of Aerosolized Nanostructured Itraconazole Formulations for Prevention of Invasive Pulmonary Aspergillosis

    J. T. McConville, D. S. Burgess, B. J. Hoeben

    págs. 1552-1554

    

  • In Vitro Activity of Tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis

    V. Thamlikitkul, S. Trakulsomboon

    págs. 1555-1557

    

  • Bactericidal Activities of R207910 and Other Newer Antimicrobial Agents against Mycobacterium leprae in Mice

    A. Chauffour, B. Ji

    págs. 1558-1560

    

  • Prevalence of First-Step Mutants among Levofloxacin-Susceptible Invasive Isolates of Streptococcus pneumoniae in the United States

    M. W. R. Pletz, A. P. Shergill

    págs. 1561-1563

    

  • Ether Lipid Ester Derivatives of Cidofovir Inhibit Polyomavirus BK Replication In Vitro

    N. A. Farasati, P. Randhawa

    págs. 1564-1566

    

  • Sequential or Combination Antifungal Therapy with Voriconazole and Liposomal Amphotericin B in a Guinea Pig Model of Invasive Aspergillosis

    W. R. Kirkpatrick

    págs. 1567-1569

    

  • Voriconazole Therapeutic Drug Monitoring

    N. Safdar, V. Knasinski, J. Smith

    págs. 1570-1572

    

  • Immunotherapy with Tacrolimus (FK506) Does Not Select for Resistance to Calcineurin Inhibitors in Candida albicans Isolates from Liver Transplant Patients

    J. L. Reedy

    págs. 1573-1577

    

  • Ritonavir Increases Plasma Amprenavir (APV) Exposure to a Similar Extent when Coadministered with Either Fosamprenavir or APV

    M. J. Shelton, M. B. Wire, K. L. Baker, L. S. Jones

    págs. 1578-1580

    

  • Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin

    G. Sakoulas

    págs. 1581-1585

    

  • New Approach for High-Throughput Screening of Drug Activity on Plasmodium Liver Stage

    A. Gego, J. F. Franetich, O. Silvie

    págs. 1586-1589

    

  • Variability in the Region Downstream of the bla~C~M~Y~-~2 beta-Lactamase Gene in Escherichia coli and Salmonella enterica Plasmids

    M.-S. Kang, T. E. Besser

    págs. 1590-1593

    

  • New Real-Time PCR Assay Using Locked Nucleic Acid Probes To Assess Prevalence of ParC Mutations in Fluoroquinolone-Susceptible Streptococcus pneumoniae from France

    J.W. Decousser

    págs. 1594-1598

    

  • Good Clinical Outcomes but High Rates of Adverse Reactions during Linezolid Therapy for Serious Infections: a Proposed Protocol for Monitoring Therapy in Complex Patients

    S. Melvani, P. G. P. Charles, E. Bishop, B. P. Howden

    págs. 1599-1602

    

  • Large Conjugative Plasmids from Clinical Strains of Salmonella enterica Serovar Virchow Contain a Class 2 Integron in Addition to Class 1 Integrons and Several Non-Integron-Associated Drug Resistance Determinants

    M. C. Mendoza, I. Rodriguez, María Rosario Rodicio Rodicio

    págs. 1603-1607

    

  • First Report of Extended-Spectrum-beta-Lactamase-Producing Salmonella enterica Isolates in Ireland

    D. Morris, G. Corrett-Feeney, M. Whelan

    págs. 1608-1609

    

  • First Isolation of bla~I~M~I~-~2 in an Enterobacter cloacae Clinical Isolate from China

    Y. G. Chen, Y.S. Yu, X.-X. Du, Z. H. Zhou

    págs. 1610-1611

    

  • Class 1 Integrons in Salmonella Strains Causing Traveler's Diarrhea

    R. Cabrera

    págs. 1612-1613